戻る Agenda
Session 5: Patient Centric Labeling: Putting the Patient at the Heart of the Label
Session Chair(s)
Megann Looker
Executive Director, Head of Global Labeling
Jazz Pharmaceuticals, United Kingdom
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan
The importance of accessible patient-centric product information in helping patients understand and adhere to their treatment is becoming even greater. The overarching role of the patient in labeling, covering aspects such as health literacy, usability requirements, and patient consultations have been discussed increasingly. In this session, we will discuss the initiatives for patient-centric product information such as the PMDA’s perspective, usability tests and the open publishing concept linking patient lay summaries with labels. There will also be discussions on strategies for involving patient insights into label development.
Learning Objective : At the conclusion of this session, participants should be able to:- Recognize the recent patient centric labeling initiatives
- Describe the concepts of health literacy and the role of usability requirements
-
Discuss the global approaches to patient labeling within a company
Speaker(s)
Regulator View: Risk Communication for Patients
Junko Sato, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director
A Novel Approach to Improving Health Literacy: Plain Language Summary Publications and Open Access Publishing
Catherine Skobe, MPH
Pfizer, Inc., United States
Senior Director, Publications Management Team Lead
Get Messages to Medicines Users: How We Can Put Their Needs First in a Regulated World
David Patrick Samuel Dickinson, MA
Consumation Ltd, Consumer Information Design, United Kingdom
Principal Consultant
Patient Experiences: Impacts of eLabeling, Readability Testing and the Inclusion of Patient Experience in Labelling
Megann Looker
Jazz Pharmaceuticals, United Kingdom
Executive Director, Head of Global Labeling